Lee Zou Named New Chair of Department of Pharmacology and Cancer Biology
October 3, 2022
Lee Zou, PhD, has been named the new chair of the Department of Pharmacology and Cancer Biology. He will begin his new role on Feb. 1, 2023. Colin Duckett, PhD, Vice Dean for Basic Science and Professor of Pharmacology and Cancer Biology, has served as interim chair of the department since September 2020.
Dr. Zou comes to Duke from Harvard Medical School, where he is a Professor of Pathology at Harvard Medical School and Scientific Co-Director of the Massachusetts General Hospital Cancer Center. He is also the James and Patricia Poitras Endowed Chair of Cancer Research, and a co-leader of the Cancer Cell Biology Program of the Dana Farber/Harvard Cancer Center. Read more.
The Peregrine Fund announces Chris Parish as new President and CEO
October 3, 2022
The Peregrine Fund’s Board of Directors is thrilled to announce Chris Parish as the new President and CEO for the organization. Parish began his career with The Peregrine Fund in November 2000 and has led The Peregrine Fund’s California Condor recovery program in northern Arizona and southern Utah. Additionally, Chris worked with partner organizations to form the North American Non-lead Partnership, which now includes more than 40 partners across the United States. Read more.
Dr. Rola El-Serag named director of Baker Institute’s Center for Health and Biosciences
October 7, 2021
HOUSTON – (Oct. 7, 2021) – Dr. Rola El-Serag will join Rice University’s Baker Institute for Public Policy Oct. 18 as the L.E. and Virginia Simmons Senior Fellow in Health Policy and director of the institute’s Center for Health and Biosciences. Read more.
Synergy Health Partners Announces Daniel G. Siegel as Chief Executive Officer
October 13, 2021
SAN DIEGO, Oct. 13, 2021 /PRNewswire/ – Synergy Health Partners, a hospital services company that improves patient access to care with custom hospital physician staffing and management programs, today announced that Daniel G. Siegel, has been named Chief Executive Officer (CEO). Mr. Siegel will lead the company in its focused strategy of serving the needs of hospitals for surgery, on-call, and emergency care. Read more.
Texas Children’s Hospital and Baylor College of Medicine name Dr. Catherine M. Gordon new Pediatrician-in-Chief and Chair of Pediatrics
April 6, 2021
HOUSTON – (April 6, 2021) – Texas Children’s Hospital and Baylor College of Medicine are proud to announce Dr. Catherine M. Gordon as the new Pediatrician-in-Chief at Texas Children’s and Chair of the Department of Pediatrics at Baylor. Gordon will join both institutions on Oct. 1. Read more.
Texas Heart Institute Announces New President and Chief Executive Officer
March 16, 2021
Houston, TX – Joseph G. Rogers, M.D., Chief Medical Officer of Duke University Health System and Professor of Medicine in Cardiology at Duke University School of Medicine, has been named President and Chief Executive Officer of the Texas Heart Institute in Houston, Texas. Read more.
Sheppard Pratt Health System Executive Vice President and Chief Operating Officer to Take Role as President and CEO of The Menninger Clinic
August 6, 2019
BALTIMORE, Aug. 6, 2019 /PRNewswire/ – Armando E. Colombo, executive vice president and chief operating officer of Sheppard Pratt Health System, has accepted the position of president and CEO of The Menninger Clinic in Houston, Texas. Read more.
Texas Children’s Hospital announces arrival of new radiologist-in-chief
September 4, 2018
Texas Children’s Hospital is excited to welcome Dr. Thierry A.G.M. Huisman as its new radiologist-in-chief. Huisman, whose appointment takes effect Sept. 4, 2018, will lead one of the nation’s most clinically and academically active radiology programs, bringing together world-class multidisciplinary expertise with leading-edge technology in a family-centered environment to provide comprehensive, accurate and safe imaging. Read more.
Healogics, Inc. Names Allan Woodward, MBA as New Chief Financial Officer
April 23, 2018
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Healogics, the nation’s largest provider of advanced chronic wound care services, today announced that it has appointed Allan Woodward to serve as Chief Financial Officer. In this role, Woodward will be responsible for the planning and oversight of the financial strategy for the company, the ongoing development of appropriate control systems and all reporting measures. Woodward will report directly to the Chief Executive Officer, David Bassin. Read more.